Home / Pharma Healthcare / Global 3D Bioprinting Market Analysis & Forecast 2016-2022

Global 3D Bioprinting Market Analysis & Forecast 2016-2022

  • Id : RNR-54101
  • Category : Pharma Healthcare
  • Publish Date : 2016
  • Pages : 0
  • Format : PDF
License Type

3D bioprinting is a process of creating cell patterns using live cells to produce living tissues, blood vessels, bones and potentially whole organs for use in various applications of the healthcare and medical industry. It involves constructing tissues wherein cell function and viability is preserved within the printed construct. 3D bioprinting technology is a small emerging segment of the mainstream global 3D printing industry. The market has been analyzed on the basis of the technology used for 3D bioprinting of tissues, as well as various application verticals which are in high need of 3D bioprinting. It further expands into key geographical regions where the 3D bioprinting market can thrive in the future. 3D bioprinting is an alternative solution for accessing organs which are bioficial (biological+ artificial) in the global market. The market is estimated to reach $581.8 million by 2022 at a CAGR of 21.7%. Even though the cost of the 3D bioprinters is high but the increasing need for organs and tissues, rising geriatric population, high investment on research and development and government support are factors that are driving the market.

 The bioprinting segment of the 3D printing industry includes living cells which are used to construct and manufacture tissues and organs. In addition to this, the report covers the market analysis of companies that are bioprinter manufacturers as well as software and service providers of 3D bio printed tissues and models.

The global 3D bioprinting market has been tracked along the lines of its technology, application areas and geography. Herein the revenue generated from the main segment of the market, the 3D bioprinters, are used to calculate the market size along with the details of various software and services shaping the market. Revenue generated from various application areas namely, drug discovery & testing, tissue engineering, research & study have also been analyzed in this report. The report also covers the 3D bioprinting market globally, consequently providing the projected revenue record of the key regions on the global map- North America, Europe, APAC, and ROW.

The technology section has been divided into extrusion based technology, photocuring based technology, magnetic bioprinting technology and others which includes the printoptical technology and the kenzan method. .The technology section lists the analysis of the 3D bioprinting market specifically based on various technologies.

3D bioprinting is mainly used for the generation and transplantation of several tissues including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures. The application section of the 3D bioprinting market has been further divided into drug discovery & testing, tissue engineering, and research & study. . Current application of organ printing is limited to in-vitro drug testing.

The reason behind drug discovery & testing application dominating the market now, and in the forecast period, is its impending need in the pharmaceutical industry for the discovery of new drugs and toxicity testing.

The geography section has been segmented into and analyzed into regions such as North America, Europe, APAC and RoW. North America was the largest revenue generating segment in 2015 as it includes both the U.S. and Canada, developed countries which are favoring the high investments and advanced technologies than any other region. Europe is the next leading region in the 3D bioprinting market after North America. It holds 35% of the global 3D bioprinter market. The APAC region is the highest growing region in 3D bioprinting market accounting for the highest CAGR among all other regions. RoW consisting of the Middle East and Africa has the least contribution in the global 3D bioprinting market due to the lack awareness about 3D bioprinting technologies.

Some of the key players in the 3D bioprinting industry are Envision TEC, RegenHU Ltd, Biobots Inc., Cellink AB, Organovo Holdings Inc, Advanced Solutions Inc, GeSIM, 3Dynamic System, Nano 3D biosciences, Poietis among others. These companies are going for intensive product launches, partnerships, agreements and collaborations to expand and consolidate the global market for 3D bioprinting.
The global 3D bioprinter market is estimated to witness a growth at a CAGR of 21.7% over the period 2016 to 2022. This growth in the market is accredited to increasing demand of tissues and organs for replacements for various applications like drug discovery & testing, tissue engineering, regenerative medicine and others. 3D bioprinting is a technology used for creating 3D print constructs within a confined space using various 3D bioprinting technologies. 3D bioprinting showcases a viable opportunity to generate patient-specific tissue for the development of accurate, targeted and completely personalised treatments.

The report is a compilation of different segments of global 3D bioprinting market including market breakdown by technology, applications and geography. It also includes sections on competitive insights and market dynamics. Herein the revenue generated from bioprinters using various bioprinting technologies, is tracked to calculate the market size along with a detailed explanation of other software and services shaping the market.

While highlighting the key driving and restraining forces for this market, the report also provides a comprehensive section of the application areas of the 3Dbioprinting market. It also details the key participants involved in the Industry.

The report answers the following questions about the global 3D bioprinting market:
•    What are the different technologies used in 3D bioprinting industry? What is their contribution in terms of revenue to the overall 3D printing Industry revenue? 
•    What are the different application areas of 3D bioprinting technology? What is their contribution in terms of revenue to the overall 3D printing Industry revenue?
•    Which is the most sought-after 3D printer type used in 3D bioprinting industry?
•    What are the basic software and services in the global 3D bioprinting market?
•    What are the different factors driving the market in the forecast period?
•    What are the factors challenging the growth of global 3D bioprinting market?
•    Who are the different participants in the global 3D bioprinting market?
•    What kind of new strategies are being adopted by existing market players to make a mark in the industry?
•    Which region will lead the global 3D bioprinting market by the end of forecast period?

The report has put special emphasis on the market share and size of extrusion based technology of 3D bioprinting industry, owing to its explicit use and benefits in the 3D bioprinting industry. The industry analysis have also been analyzed the impact of various factors to understand the overall attractiveness of the industry. 

The most often used strategy for developing a better hold on to the market has been through product launches, followed by agreements, collaborations and partnerships. The systems segment of the 3D bioprinting market implies that market participants are more varied in nature. Moreover, the company profile section includes highlights of significant information about the key companies involved along with their financial positions key strategies & developmental activities of recent years. Some of the key players involved in this market are Envision TEC, RegenHU Ltd, Organovo Holdings Inc, Biobots Inc, 3D Biotek LLC, Nano3D Biosciences, Poietis among others.

North America generated the maximum amount of revenue in the year 2015 in the global 3D bioprinting market among all the regions .However, APAC has the maximum potential to grow in the forecast period, followed by Europe. If the industry has the prospects of growing with the same pace, it will cross $ 581.8 million in total market value by the end of forecast period.